Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

CCK antagonists from Warner-Lambert

Aug. 30, 1996

NGD-95-1 demonstrates safety in phase I

Aug. 30, 1996

More squalene synthase inhibitors from Pfizer

Aug. 30, 1996

Xenical to be marketed in 1997

Aug. 30, 1996

SDZ-266806: A novel squalene synthase inhibitor

Aug. 30, 1996

Estrogenic compounds from Sankyo

Aug. 30, 1996

Prophylactic tibolone shown effective in 2 year study

Aug. 30, 1996

Columbia Laboratories granted U.S. patent for Crinone technology

Aug. 23, 1996

Astra's Atmos launched in Sweden

Aug. 23, 1996

Humatrope approved for new indication in U.S.

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...